Last deal

$35M

Amount

Series D

Stage

05.01.2023

Date

12

all rounds

$209.7M

Total amount

General

About Company
Cardiac Dimensions develops medical devices for heart failure and related conditions.

Industry

Sector :

Subsector :

founded date

01.01.2001

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company's Carillon® Mitral Contour System® is a non-surgical device that reshapes the mitral valve and reduces mitral regurgitation, improving long-term survival for patients. This therapy is the only indirect, no-touch mitral valve repair option designed to produce an annuloplasty effect while initiating left ventricular remodeling. It can be used alongside other HF treatments and treats the underlying causes of mitral insufficiency, allowing patients to live longer, higher quality lives. Visit their website to learn more about this groundbreaking solution.
Contacts